INTENSITY THERAPEUTICS, INC.

Profile

Company Names

INTENSITY THERAPEUTICS, INC.

Addresses

1 ENTERPRISE DRIVE, SUITE 430, SHELTON, CT 06484

8 WRIGHT STREET, SUITE 107, WESTPORT, CT 06880

8 WRIGHT STREET, SUITE 107, WESTPORT, CT 06880

40 RICHARDS AVENUE, 3RD FLOOR, NORWALK, CT 06854

Phone Numbers

203-221-7381
914-329-6571
203-682-2434

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$5,899,483.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2024-11-21 
$3,649,483.00 
$3,649,483.00 
$0.00 
 
2
2015-05-18 
$500,000.00 
$5,000,000.00 
$4,500,000.00 
Equity 
1
2013-01-05 
$1,750,000.00 
INDEFINITE 
INDEFINITE 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LEWIS 
H. 
BENDER 
EXECUTIVE OFFICER, DIRECTOR
INTERLEUKIN GENETICS INC   |  INTENSITY THERAPEUTICS, INC.
ROBERT 
 
COOKE 
EXECUTIVE OFFICER
INTENSITY THERAPEUTICS, INC.   |  RIVERBANK HOLDING CO
DANIEL 
 
DONOVAN 
DIRECTOR
CANCER PREVENTION PHARMACEUTICALS, INC.   |  PANBELA THERAPEUTICS, INC.   |  INTENSITY THERAPEUTICS, INC.
THOMAS 
I.H. 
DUBIN 
DIRECTOR
INTENSITY THERAPEUTICS, INC.
MARK 
A. 
GOLDBERG 
DIRECTOR
INTENSITY THERAPEUTICS, INC.
EMER 
 
LEAHY 
DIRECTOR
PSYLIN NEUROSCIENCES INC   |  BRIGHT MINDS BIOSCIENCES INC.   |  PASITHEA THERAPEUTICS CORP.   |  INTENSITY THERAPEUTICS, INC.
JOSEPH 
 
TALAMO 
EXECUTIVE OFFICER
NEOSTEM, INC.   |  CALADRIUS BIOSCIENCES, INC.   |  INTENSITY THERAPEUTICS, INC.
IAN 
B. 
WALTERS, M.D. 
EXECUTIVE OFFICER
INTENSITY THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-12-05
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
 
2024-11-21 
2015-06-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-18 
2014-12-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2013-01-05 
2014-02-11
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2013-01-05 
2013-01-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2013-01-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
A.G.P./ALLIANCE GLOBAL PARTNERS
8361
NONE
NONE
BROOKLINE CAPITAL MARKETS, A DIVISION OF ARCADIA SECURITIES, LLC
44656
NONE
NONE
CATO CAPITAL, LLC
133142